Retractable Technologies Inc (RVP)

[Enterprising Investor]

Retractable Technologies, Inc. Files Motions in Connection with Becton, Dickinson and Co. Judgment (9/15/17)

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP), (“RTI”) reports that on September 13, 2017, it filed a Motion to Alter or Amend the Judgment issued by the United States District Court for the Eastern District of Texas on August 17, 2017 which had ordered that RTI take nothing in its suit against Becton, Dickinson and Co. (“BD”). Such Motion asked the Court to require BD to notify end users of the facts relating to syringes, as required by the original injunction in this case.

RTI additionally reports that on September 14, 2017, it filed a Notice of Appeal to the United States Court of Appeals for the Fifth Circuit relating to the August 17 judgment discussed above.

Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.

For more information on Retractable, visit its website at www.retractable.com.

http://www.businesswire.com/news/home/20170915005936/en/Retractable-Technologies-Files-Motions-Connection-Becton-Dickinson